PeptidesSystematic review and network meta-analysis
GLP-1 weight loss still needs muscle guardrails
When GLP-1s enter the conversation, the coaching job is not to hype the drug. It is to protect protein, lifting, function, and sustainable habits while weight drops.
- Claim guardrail
- Medication decisions belong with a qualified clinician. Use this for body-composition education, not prescribing, dosing, or medical risk claims.
PeptidesRandomized trial body-composition analysis
Tirzepatide changes fat and lean mass
A medication-driven cut still needs the boring coaching basics: lift, eat enough protein, track strength, and keep the goal bigger than scale loss.
- Claim guardrail
- Do not interpret body-composition trial data as individual medical advice. Keep all medication and side-effect decisions with the prescriber.
PeptidesSystematic review
Semaglutide lean-mass data needs context
The practical question for a regular person is not whether the medication works for weight loss. It is whether the plan preserves strength, protein, steps, and long-term eating skills.
- Claim guardrail
- Do not give semaglutide guidance, contraindication advice, or dose advice. Keep this as a training-and-nutrition guardrail around clinician-led care.
PeptidesClinical perspective
Resistance exercise belongs beside GLP-1 care
The strongest practical message is simple: if appetite is lower and body weight is dropping, resistance training becomes more important, not less.
- Claim guardrail
- This is not a substitute for medical supervision. Keep claims to exercise and body-composition support, not medication management.
PeptidesIntegrative review
Collagen peptides are not a muscle-building shortcut
Collagen belongs in the recovery and tendon-joint conversation before it belongs in a muscle-growth promise. Training, total protein, and calories still run the physique plan.
- Claim guardrail
- Do not market collagen peptides as a proven hypertrophy replacement for complete protein or progressive resistance training.
PeptidesSystematic review
BPC-157 has hype, but human evidence is still limited
When clients ask about BPC-157, the honest coaching answer is to separate internet recovery hype from verified human clinical outcomes and medical supervision.
- Claim guardrail
- Do not recommend, source, dose, or normalize BPC-157. Treat it as a medical/regulatory question with limited human evidence, not a coaching supplement.
PeptidesClinical primer
Injectable peptides need clinician-level caution
The regular-person takeaway is caution: injectable peptides are not a normal fitness habit, and recovery decisions should start with diagnosis, rehab, sleep, nutrition, and qualified care.
- Claim guardrail
- Do not provide injectable peptide guidance, sourcing, dosing, legality, or safety assurances. Keep this as a why-to-ask-a-clinician page.
PeptidesClinical review
GLP-1 body-composition changes need a muscle plan
The practical GLP-1 takeaway is not fear. It is to plan for resistance training, protein, and strength tracking while weight is changing quickly.
- Source
- Bhandarkar, Bhat, and Kapoor. Current Opinion in Endocrinology, Diabetes, and Obesity. 2025. PMID 41076575.
- PubMed sourceLibrary card
- Claim guardrail
- Do not give GLP-1 medical guidance, dosing, contraindication, or side-effect advice. Keep the coaching layer to training, protein, recovery, and clinician-led care.
PeptidesJoint advisory
GLP-1 nutrition still needs protein and habits
A GLP-1 can reduce appetite, but the nutrition plan still has to protect protein, micronutrient quality, training fuel, and long-term routines.
- Claim guardrail
- Do not position coaching as medication management. Nutrition and training support can complement clinician-led treatment, not replace it.
PeptidesNarrative review
GLP-1 users may need nutrition support, not less structure
If appetite is suppressed, the coaching problem can flip from eating less to eating enough of the right things often enough.
- Source
- Chavez, Carrasco Barria, and Leon-Sanz. Current Opinion in Clinical Nutrition and Metabolic Care. 2025. PMID 40401903.
- PubMed sourceLibrary card
- Claim guardrail
- Do not provide medical nutrition therapy. Use this as a reason to coordinate with clinicians when medication, low intake, or health conditions are involved.
PeptidesRandomized controlled trial protocol
Researchers are testing protein plus lifting during GLP-1 therapy
This is not an outcome paper yet, but it shows the right practical question: can resistance exercise and protein protect muscle while GLP-1 weight loss happens?
- Claim guardrail
- Label this as a protocol, not proof of effectiveness. Do not imply the trial has already shown results.
PeptidesPreclinical and human body-composition study
GLP-1 muscle loss claims need nuance
The stronger claim is nuance: rapid weight loss deserves strength and protein support, but panic headlines about GLP-1s automatically wrecking muscle are too blunt.
- Claim guardrail
- Do not generalize beyond the study design or make medication-safety claims. Keep advice focused on monitoring strength, intake, and function with clinician oversight.
PeptidesSystematic review and meta-analysis of randomized trials
GLP-1 weight loss needs a muscle plan
The useful coaching message is specific: significant weight loss often includes lean-mass loss, and resistance training plus adequate protein improves the profile.
- Claim guardrail
- Do not frame this as anti-medication advice. Medication decisions stay clinician-led; coaching focuses on muscle-preserving habits and monitoring.
PeptidesSystematic review and network meta-analysis of randomized trials
GLP-1s lower fat, but lean mass still needs attention
Body-composition data makes the coaching layer clear: fat loss can improve, but strength, protein, and lean-mass monitoring should not be ignored.
- Claim guardrail
- Do not compare medications, doses, or side effects for clients. Use this only to explain why body composition matters during clinician-managed care.
PeptidesSystematic review
Fat loss and muscle loss must be separated
For regular people, the action is not arguing about the scale. It is tracking strength, protein, function, and body-composition signals when weight is moving fast.
- Claim guardrail
- Do not imply a home scale can diagnose muscle loss. Body-composition methods vary, and medical interpretation belongs with clinicians.
PeptidesNarrative review
Low appetite can create nutrition gaps
When appetite drops hard, the nutrition plan has to protect protein, fluids, fiber, calcium/iron-rich foods, and clinician-directed lab follow-up when risk is present.
- Claim guardrail
- This is not a diagnosis or supplement prescription. The review is mainly observational, and lab testing or supplementation belongs with qualified clinicians.